{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:14:18Z","timestamp":1782706458858,"version":"3.54.5"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic use of benzodiazepine receptor agonists (BZRAs) remains common among adults aged 65\u00a0years and older, despite long-standing concerns regarding falls, cognitive impairment, functional decline and other adverse outcomes. Multiple strategies to support the deprescribing of BZRAs have been proposed; however, the safety and effectiveness of these deprescribing interventions in older adults have not been comprehensively synthesized across different intervention types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To synthesize the available evidence on the safety and effectiveness of structured strategies to deprescribe chronic BZRA use in adults aged \u226565\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review was conducted in accordance with PRISMA 2020 guidelines. Ovid MEDLINE, PubMed, Embase and PsycINFO were searched from database inception to September 2025. Randomized and nonrandomized studies evaluating structured BZRA-deprescribing interventions in older adults were included. Risk of bias was assessed using design-appropriate tools, and findings were synthesized narratively due to substantial heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty studies involving ~11\u00a0000 older adults were included. Interventions encompassed structured pharmacologic tapering, patient-directed educational strategies, clinician-led approaches and system-level interventions. Across strategies, deprescribing was generally safe, with withdrawal symptoms typically mild and transient and serious adverse events rare. Structured gradual tapering achieved the highest rates of discontinuation or dose reduction, while other approaches demonstrated more variable effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Deprescribing chronic BZRA use in older adults is feasible and generally safe when implemented using structured, gradual and patient-centred approaches. Effectiveness varies by intervention type and context, supporting an individualized, evidence-informed approach to deprescribing in geriatric practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol registration<\/jats:title>\n                    <jats:p>International Prospective Register of Systematic Reviews (PROSPERO): CRD420251186411.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag112","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:20:56Z","timestamp":1776079256000},"source":"Crossref","is-referenced-by-count":1,"title":["Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6220-7310","authenticated-orcid":false,"given":"Kevin","family":"O'Hara-Veintimilla","sequence":"first","affiliation":[{"name":"Psychogeriatric Unit, Cl\u00ednica Psicogeri\u00e1trica Josefina Arregui, Erburua s\/n Altsasu , Altsasu, Navarra 31800 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00f3n","family":"P\u00e1ez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Semillero de Neurociencias y Envejecimiento, Pontificia Universidad Javeriana , Bogot\u00e1 ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Ramirez-Triana","sequence":"additional","affiliation":[{"name":"Semillero de Neurociencias y Envejecimiento, Pontificia Universidad Javeriana , Bogot\u00e1 ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiara","family":"Torres-Tello","sequence":"additional","affiliation":[{"name":"Semillero de Neurociencias y Envejecimiento, Pontificia Universidad Javeriana , Bogot\u00e1 ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Verhelst-Forero","sequence":"additional","affiliation":[{"name":"Intellectus Centro de Memoria y Cognici\u00f3n, Hospital Universitario San Ignacio, Bogota ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-0603","authenticated-orcid":false,"given":"Miguel German","family":"Borda Borda","sequence":"additional","affiliation":[{"name":"Centre for Age-Related Medicine (SESAM), Stavanger University Hospital , Stavanger,","place":["Norway"]},{"name":"Department of Neurology, Cl\u00ednica Universidad de Navarra , Pamplona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2026050608275000700_ref1","doi-asserted-by":"publisher","first-page":"e230044","DOI":"10.1001\/jamanetworkopen.2023.0044","article-title":"Benzodiazepine receptor agonists prescribing for insomnia among adults in primary health care facilities in Beijing, China","volume":"6","author":"Fu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026050608275000700_ref2","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11606-025-09499-2","article-title":"Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits","volume":"40","author":"Brunner","year":"2025","journal-title":"J Gen Intern Med"},{"key":"2026050608275000700_ref3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2026050608275000700_ref4","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25m16125","article-title":"Trends in benzodiazepine prescribing to adults in the United States: results from the medical expenditure panel survey","volume":"87","author":"Olfson","year":"2026","journal-title":"J Clin Psychiatry"},{"key":"2026050608275000700_ref5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s41999-025-01214-y","article-title":"Improving usability of the STOPP\/START version 3 criteria: development of a practice tool for clinicians, students and researchers","volume":"16","author":"Dalleur","year":"2025","journal-title":"Eur Geriatr Med"},{"key":"2026050608275000700_ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jgs.18668","article-title":"The Beers Criteria then and now","volume":"72","author":"Rochon","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/gps.5494","article-title":"Benzodiazepines and antidepressants: effects on cognitive and functional decline in Alzheimer\u2019s disease and Lewy body dementia","volume":"36","author":"Borda","year":"2021","journal-title":"Int J Geriat Psychiatry"},{"key":"2026050608275000700_ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HRP.0000000000000414","article-title":"Chronic use of benzodiazepine in older adults and its relationship with dementia: a systematic review and meta-analysis","volume":"33","author":"Rivas","year":"2025","journal-title":"Harv Rev Psychiatry"},{"key":"2026050608275000700_ref9","doi-asserted-by":"publisher","first-page":"101591","DOI":"10.1016\/j.lanwpc.2025.101591","article-title":"A decade of benzodiazepine and Z-drug use in Hong Kong: a longitudinal study","volume":"59","author":"Lee","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"2026050608275000700_ref10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"2026050608275000700_ref11","doi-asserted-by":"publisher","first-page":"afaf342","DOI":"10.1093\/ageing\/afaf342","article-title":"Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe","volume":"54","author":"Shapoval","year":"2025","journal-title":"Age Ageing"},{"key":"2026050608275000700_ref12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00228-020-03007-7","article-title":"Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?","volume":"77","author":"Jobert","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"2026050608275000700_ref13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"2026050608275000700_ref14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Implementation Sci"},{"key":"2026050608275000700_ref15","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/jgs.19512","article-title":"Deprescribing benzodiazepine receptor agonists in older adults and people with cognitive impairment: a systematic review","volume":"73","author":"McEvoy","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"},{"key":"2026050608275000700_ref17","doi-asserted-by":"publisher","first-page":"e081336","DOI":"10.1136\/bmj-2024-081336","article-title":"Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis","volume":"389","author":"Zeraatkar","year":"2025","journal-title":"BMJ"},{"key":"2026050608275000700_ref18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/add.15997","article-title":"Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis","volume":"118","author":"Soni","year":"2023","journal-title":"Addiction"},{"key":"2026050608275000700_ref19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamainternmed.2022.6545","article-title":"Deprescribing medications among older adults from end of hospitalization through Postacute care: a shed-MEDS randomized clinical trial","volume":"183","author":"Vasilevskis","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026050608275000700_ref20","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"2026050608275000700_ref21","doi-asserted-by":"publisher","first-page":"e2165","DOI":"10.1002\/hsr2.2165","article-title":"The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: a perspective on the pros and cons","volume":"7","author":"Nejadghaderi","year":"2024","journal-title":"Health Sci Rep"},{"key":"2026050608275000700_ref22","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026050608275000700_ref23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid Synth"},{"key":"2026050608275000700_ref24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","article-title":"Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation","volume":"13","author":"Lockwood","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2026050608275000700_ref25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF02942077","article-title":"Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal","volume":"158","author":"Tham","year":"1989","journal-title":"Ir J Med Sci"},{"key":"2026050608275000700_ref26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s002280050213","article-title":"Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research","volume":"51","author":"Habraken","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"2026050608275000700_ref27","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1532-5415.1999.tb03843.x","article-title":"Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized controlled trial","volume":"47","author":"Campbell","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-001-0387-4","article-title":"Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial","volume":"57","author":"Petrovic","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"2026050608275000700_ref29","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1017\/S0033291703008213","article-title":"Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life","volume":"33","author":"Curran","year":"2003","journal-title":"Psychol Med"},{"key":"2026050608275000700_ref30","first-page":"835","article-title":"Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial","volume":"168","author":"Pimlott","year":"2003","journal-title":"CMAJ"},{"key":"2026050608275000700_ref31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/fampra\/cmi105","article-title":"Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden","volume":"23","author":"Midl\u00f6v","year":"2006","journal-title":"Fam Pract"},{"key":"2026050608275000700_ref32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/BF03324897","article-title":"Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Garz\u00f3n","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"2026050608275000700_ref33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3821\/1913-701X-143.6.286","article-title":"Discontinuing benzodiazepine therapy: an interdisciplinary approach at a geriatric day hospital","volume":"143","author":"Chen","year":"2010","journal-title":"Can Pharm J"},{"key":"2026050608275000700_ref34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/11584480-000000000-00000","article-title":"Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective cohort study","volume":"27","author":"Joester","year":"2010","journal-title":"Drugs Aging"},{"key":"2026050608275000700_ref35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ageing\/afp255","article-title":"One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons","volume":"39","author":"Salonoja","year":"2010","journal-title":"Age Ageing"},{"key":"2026050608275000700_ref36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ggi.12113","article-title":"Benzodiazepine discontinuation and patient outcome in a chronic geriatric medical\/psychiatric unit: a retrospective chart review","volume":"14","author":"Yokoi","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"2026050608275000700_ref37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","article-title":"Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study","volume":"70","author":"Bourgeois","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"2026050608275000700_ref38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2026050608275000700_ref39","doi-asserted-by":"publisher","first-page":"e015959","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"key":"2026050608275000700_ref40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"2026050608275000700_ref41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4140\/TCP.n.2018.711","article-title":"Clinical pharmacist intervention to engage older adults in reducing use of alprazolam","volume":"33","author":"Navy","year":"2018","journal-title":"Consult Pharm"},{"key":"2026050608275000700_ref42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/jgs.15300","article-title":"EMPOWERing hospitalized older adults to deprescribe sedative hypnotics: a pilot study","volume":"66","author":"Wilson","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.9740\/mhc.2018.05.100","article-title":"Effectiveness of a direct-to-consumer written health education program in the reduction of benzodiazepine and sedative-hypnotic use in an elderly population at a single Veterans Affairs medical center","volume":"8","author":"Erwin","year":"2018","journal-title":"Ment Health Clin"},{"key":"2026050608275000700_ref44","doi-asserted-by":"publisher","first-page":"e000539","DOI":"10.1136\/bmjoq-2018-000539","article-title":"Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative","volume":"8","author":"Carr","year":"2019","journal-title":"BMJ Open Qual"},{"key":"2026050608275000700_ref45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7812\/TPP\/18-161","article-title":"Patient education and pharmacist consultation influence on nonbenzodiazepine sedative medication deprescribing success for older adults","volume":"23","author":"Kuntz","year":"2019","journal-title":"Perm J"},{"key":"2026050608275000700_ref46","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","article-title":"Benzodiazepine use and deprescribing in Belgian nursing homes: results from the COME-ON study","volume":"68","author":"Evrard","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12875-021-01415-x","article-title":"Reducing prescribing of benzodiazepines in older adults: a comparison of four physician-focused interventions by a medical regulatory authority","volume":"22","author":"Ashworth","year":"2021","journal-title":"BMC Fam Pract"},{"key":"2026050608275000700_ref48","doi-asserted-by":"publisher","first-page":"e1003983","DOI":"10.1371\/journal.pmed.1003983","article-title":"Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners: the BENZORED hybrid type 1 cluster randomized controlled trial","volume":"19","author":"Vicens","year":"2022","journal-title":"PLoS Med"},{"key":"2026050608275000700_ref49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/pharmacy10050120","article-title":"A need for benzodiazepine deprescribing in the COVID-19 pandemic: a cohort study","volume":"10","author":"Bu\u017ean\u010di\u0107","year":"2022","journal-title":"Pharmacy"},{"key":"2026050608275000700_ref50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11096-021-01371-7","article-title":"Deprescribing clonazepam in primary care older patients: a feasibility study","volume":"44","author":"Da Silva","year":"2022","journal-title":"Int J Clin Pharmacol"},{"key":"2026050608275000700_ref51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/07317115.2022.2130849","article-title":"Pilot RCT testing a mailing about sleeping pills and cognitive Behavioral therapy for insomnia: impact on benzodiazepines and Z-drugs","volume":"47","author":"Mak","year":"2022","journal-title":"Clin Gerontol"},{"key":"2026050608275000700_ref52","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40266-023-01029-1","article-title":"Benzodiazepine receptor agonists use and cessation among multimorbid older adults with polypharmacy: secondary analysis from the OPERAM trial","volume":"40","author":"Sibille","year":"2023","journal-title":"Drugs Aging"},{"key":"2026050608275000700_ref53","doi-asserted-by":"publisher","first-page":"e2424234","DOI":"10.1001\/jamanetworkopen.2024.24234","article-title":"Reducing central nervous system\u2013active medications to prevent falls and injuries among older adults: a cluster randomized clinical trial","volume":"7","author":"Phelan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026050608275000700_ref54","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jgs.18728","article-title":"Evaluation of a benzodiazepine deprescribing quality improvement initiative for older adults in primary care","volume":"72","author":"Chae","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"2026050608275000700_ref55","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.3399\/bjgp11X593857","article-title":"Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis","volume":"61","author":"Mugunthan","year":"2011","journal-title":"Br J Gen Pract"},{"key":"2026050608275000700_ref56","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/add.14981","article-title":"Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis","volume":"115","author":"Lynch","year":"2020","journal-title":"Addiction"},{"key":"2026050608275000700_ref57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1192\/bjp.189.3.213","article-title":"Strategies for discontinuing long-term benzodiazepine use: Meta-analysis","volume":"189","author":"Voshaar","year":"2006","journal-title":"Br J Psychiatry"},{"key":"2026050608275000700_ref58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","article-title":"Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis","volume":"104","author":"Parr","year":"2009","journal-title":"Addiction"},{"key":"2026050608275000700_ref59","doi-asserted-by":"publisher","first-page":"CD011481","DOI":"10.1002\/14651858.CD011481.pub2","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026050608275000700_ref60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamainternmed.2025.6084","article-title":"Implementing benzodiazepine deprescribing in the primary care clinic","volume":"186","author":"Shuey","year":"2025","journal-title":"JAMA Intern Med"},{"key":"2026050608275000700_ref61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/ageing\/afy075","article-title":"Effectiveness of a multifaceted intervention to reduce night-time sedative use in a rehabilitation unit: a pre\u2013post intervention study","volume":"47","author":"Reyes","year":"2018","journal-title":"Age Ageing"},{"key":"2026050608275000700_ref62","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.smrv.2019.101214","article-title":"Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: a systematic review and meta-analysis","volume":"48","author":"Takaesu","year":"2019","journal-title":"Sleep Med Rev"},{"key":"2026050608275000700_ref63","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamapsychiatry.2024.2731","article-title":"Patient self-guided interventions to reduce sedative use and improve sleep: the YAWNS NB randomized clinical trial","volume":"81","author":"Gardner","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"2026050608275000700_ref64","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/14740338.2014.925444","article-title":"Risk versus risk: a review of benzodiazepine reduction in older adults","volume":"13","author":"Paquin","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2026050608275000700_ref65","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"2026050608275000700_ref66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/104012372003200214","article-title":"Systematic review of benzodiazepines for anxiety disorders in late life","volume":"32","author":"Gupta","year":"2020","journal-title":"Ann Clin Psychiatry"},{"key":"2026050608275000700_ref67","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders: a review","volume":"328","author":"Szuhany","year":"2022","journal-title":"JAMA"},{"key":"2026050608275000700_ref68","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJMra2116304","article-title":"Catatonia","volume":"389","author":"Heckers","year":"2023","journal-title":"N Engl J Med"},{"key":"2026050608275000700_ref69","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.jpainsymman.2022.11.018","article-title":"Should benzodiazepines be used for reducing dyspnea in patients with advanced illnesses?","volume":"65","author":"Simon","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"2026050608275000700_ref70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMcp2305655","article-title":"Management of insomnia","volume":"391","author":"Morin","year":"2024","journal-title":"N Engl J Med"},{"key":"2026050608275000700_ref71","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1111\/jgs.19500","article-title":"Alternative treatments to selected medications in the 2023 American Geriatrics Society Beers Criteria\u00ae","volume":"73","author":"American Geriatrics Society Beers Criteria\u00ae Alternatives Panel, Steinman MA","year":"2025","journal-title":"J Am Geriatr Soc"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/5\/afag112\/68226657\/afag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/5\/afag112\/68226657\/afag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:28:00Z","timestamp":1778070480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag112\/8670406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag112","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"afag112"}}